{"disease":{"id":"adpkd","name":"adpkd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06416761","title":"Genetics in the Progression of Nephropathies","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Ospedale San Raffaele","has_results":false},{"nct_id":"NCT02112136","title":"Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD","phase":"NA","overall_status":"COMPLETED","enrollment_count":1450,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT01214421","title":"Tolvaptan Extension Study in Participants With ADPKD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1083,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT03918447","title":"A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":667,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT02925221","title":"Canadian Medical Assessment of JINARC™ Outcomes Registry","phase":"","overall_status":"COMPLETED","enrollment_count":530,"lead_sponsor_name":"Otsuka Canada Pharmaceutical Inc.","has_results":false},{"nct_id":"NCT06747572","title":"Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":401,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT06618638","title":"Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment","phase":"NA","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04338048","title":"Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT06085807","title":"Genetic Testing in Autosomal Dominant Polycystic Kidney Disease","phase":"","overall_status":"COMPLETED","enrollment_count":226,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05014178","title":"Kidney Sodium Functional Imaging","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT06759142","title":"Analysis of Patients With Autosomal Dominant Polycystic Kidney","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT06345755","title":"A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT02127437","title":"Lanreotide In Polycystic Kidney Disease Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04689074","title":"Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","has_results":false},{"nct_id":"NCT03764605","title":"Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","has_results":false},{"nct_id":"NCT03273413","title":"Statin Therapy in Patients With Early Stage ADPKD","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT06800651","title":"Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":135,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT07282821","title":"Bempedoic Acid Therapy for Polycystic Kidney Disease","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Kenneth Hallows","has_results":false},{"nct_id":"NCT03949894","title":"Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Korea Otsuka Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07565441","title":"Drug-Drug Interactions of JMKX003142 in Healthy Participants","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":112,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT02964273","title":"Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT03203642","title":"Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Kadmon, a Sanofi Company","has_results":true},{"nct_id":"NCT07074327","title":"Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT05521191","title":"A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Regulus Therapeutics Inc.","has_results":false},{"nct_id":"NCT04680780","title":"Ketogenic Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease (ADPKD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"University of Cologne","has_results":false},{"nct_id":"NCT07355114","title":"Robotic vs Open Nephrectomy for ADPKD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":57,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT06658964","title":"Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT07181265","title":"Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT07022119","title":"A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT07535385","title":"RADIOLOGICAL AND CLINICAL EVALUATION OF RENAL EMBOLIZATION USING EVOH IN DIALYSIS PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A PROSPECTIVE LONGITUDINAL OBSERVATIONAL STUDY","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT07470177","title":"A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT03717883","title":"ADPKD Alterations in Hepatic Transporter Function","phase":"","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT07161037","title":"Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT02616055","title":"Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Kadmon Corporation, LLC","has_results":false},{"nct_id":"NCT04064346","title":"Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Palladio Biosciences","has_results":true},{"nct_id":"NCT06594367","title":"A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo Province","phase":"","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Mario Negri Institute for Pharmacological Research","has_results":false},{"nct_id":"NCT04472624","title":"Short Term Induction of Ketosis in PKD","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"University of Cologne","has_results":false},{"nct_id":"NCT07463053","title":"Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":8,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT04152837","title":"Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Palladio Biosciences","has_results":true}],"total":39},"guidelines":[],"source":"Drug Landscape verified database"}